| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |